BMEA
Price
$1.98
Change
-$0.18 (-8.33%)
Updated
Apr 3, 02:31 PM (EDT)
Capitalization
78.28M
27 days until earnings call
IDYA
Price
$15.44
Change
-$0.91 (-5.57%)
Updated
Apr 3, 04:09 PM (EDT)
Capitalization
1.43B
40 days until earnings call
Ad is loading...

BMEA vs IDYA

Header iconBMEA vs IDYA Comparison
Open Charts BMEA vs IDYABanner chart's image
Biomea Fusion
Price$1.98
Change-$0.18 (-8.33%)
Volume$200
Capitalization78.28M
IDEAYA Biosciences
Price$15.44
Change-$0.91 (-5.57%)
Volume$6.11K
Capitalization1.43B
BMEA vs IDYA Comparison Chart
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. IDYA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and IDYA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BMEA: $2.16 vs. IDYA: $16.35)
Brand notoriety: BMEA and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 153% vs. IDYA: 216%
Market capitalization -- BMEA: $78.28M vs. IDYA: $1.43B
BMEA [@Biotechnology] is valued at $78.28M. IDYA’s [@Biotechnology] market capitalization is $1.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, BMEA is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • BMEA’s TA Score: 4 bullish, 4 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BMEA and IDYA are a good buy in the short-term.

Price Growth

BMEA (@Biotechnology) experienced а -14.29% price change this week, while IDYA (@Biotechnology) price change was -6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 30, 2025.

IDYA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.43B) has a higher market cap than BMEA($78.3M). IDYA YTD gains are higher at: -36.381 vs. BMEA (-44.330). BMEA has higher annual earnings (EBITDA): -149.62M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. BMEA (88M). BMEA has less debt than IDYA: BMEA (9.57M) vs IDYA (19.2M). IDYA has higher revenues than BMEA: IDYA (7M) vs BMEA (0).
BMEAIDYABMEA / IDYA
Capitalization78.3M1.43B5%
EBITDA-149.62M-323.14M46%
Gain YTD-44.330-36.381122%
P/E RatioN/AN/A-
Revenue07M-
Total Cash88M676M13%
Total Debt9.57M19.2M50%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEAIDYA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNNGY14.920.47
+3.25%
Orsted A/S
FARM2.250.04
+1.81%
Farmer Brothers Company
MEGEF17.60-0.04
-0.23%
Meg Energy Corp.
EBKDY34.82-0.10
-0.29%
Erste Group Bank AG
FFMGF0.09N/A
-2.16%
First Mining Gold Corp.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+8.54%
ARCT - BMEA
50%
Loosely correlated
+8.17%
BAIVF - BMEA
32%
Poorly correlated
N/A
KROS - BMEA
31%
Poorly correlated
+5.13%
IDYA - BMEA
30%
Poorly correlated
+10.70%
PRME - BMEA
30%
Poorly correlated
+0.28%
More